Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Dinaciclib

EU orphan designation number: EU/3/11/901   
Active ingredient: Dinaciclib
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/052/11 (2011)7034 of 27/09/2011